Back
Allogene Therapeutics Vs. Kyndryl Holdings Industry Stock Comparison
Sell
13
ALLO
Allogene Therapeutics
Last Price:
2.21
Seasonality Move:
6.59%
Sell
22
KD
Kyndryl Holdings
Last Price:
33.07
Seasonality Move:
21.65%
Sell
13
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.11. The Score for ALLO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Kyndryl Holdings (KD)
is a Sell
Is Kyndryl Holdings a Buy, Sell or Hold?
- The current Kyndryl Holdings [KD] share price is $32.49. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing buying pressure, which is a positive indicator for future bullish movement.
KD Stock Price Chart
What is Kyndryl Holdings's stock price today?
-
The Kyndryl Holdings share price today is $32.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALLO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 34.29 | Sell |
| Chaikin Money Flow: | 1048716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 3) | Sell |
| Bollinger Bands (100): | (2.39 - 2.95) | Sell |
KD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.52 | Buy |
| Relative Strength Index (14 RSI): | 83.94 | Buy |
| Chaikin Money Flow: | 4050180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.38 - 28.4) | Buy |
| Bollinger Bands (100): | (22.65 - 26.71) | Buy |
ALLO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.66 | Sell |
| 50-day SMA: | 2.7 | Sell |
| 200-day SMA: | 3.13 | Sell |
| 8-day EMA: | 2.32 | Sell |
| 20-day EMA: | 2.55 | Sell |
| 50-day EMA: | 2.65 | Sell |
| 200-day EMA: | 3.03 | Sell |
KD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.77 | Buy |
| 20-day SMA: | 26.27 | Buy |
| 50-day SMA: | 24.78 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 28.86 | Buy |
| 20-day EMA: | 27.1 | Buy |
| 50-day EMA: | 25.54 | Buy |
| 200-day EMA: | 23.47 | Buy |
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
Kyndryl Holdings Earnings Growth & KD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.
Allogene Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kyndryl Holdings Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||